SCHEMBL26685482

SCHEMBL26685482

CC(=O)N1CC(c2ccc3cc(OS(=O)(=O)C(F)(F)F)nnc3c2)C1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 4/20 0.38
▸ DRD1 P21728 4/20 0.38
▸ DRD4 P21917 4/20 0.38
▸ DRD5 P21918 4/20 0.38
▸ DRD3 P35462 4/20 0.38
▸ HSD11B1 P28845 1/20 0.35
▸ MAP3K12 Q12852 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ TACR1 P25103 2/20 0.32
▸ SCD O00767 1/20 0.32
▸ SCD5 Q86SK9 1/20 0.32
▸ QDPR P09417 2/20 0.32
▸ SCN9A Q15858 2/20 0.31
▸ SOS1 Q07889 1/20 0.31
▸ SCN7A Q01118 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ SCN5A Q14524 1/20 0.31
▸ RORC P51449 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26685251 0.92 DRD2 (0.38) DRD2DRD1DRD4DRD5DRD3
SCHEMBL26685113 0.82 DPP4 (0.32) DRD2DRD1DRD4DRD5DRD3
SCHEMBL31570167 0.82 DPP4 (0.32) DRD2DRD1DRD4DRD5DRD3
SCHEMBL31570183 0.76 QDPR (0.42) MAP3K12PDE4BSCD5QDPR
SCHEMBL26685131 0.76 QDPR (0.42) MAP3K12PDE4BSCD5QDPR
SCHEMBL12679145 0.73 ALDH1A1 (0.37) HSD11B1
SCHEMBL26685057 0.72 SMARCA2 (0.47) QDPR
SCHEMBL31570168 0.72 SMARCA2 (0.47) QDPR
SCHEMBL1574305 0.71 PDE4A (0.46) DRD2DRD4DRD3HSD11B1
SCHEMBL30046151 0.71 PDE4A (0.46) DRD2DRD4DRD3HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522278-A1 BENZOYPARAZINE PYRAZINES ANE THEIR USES Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220129-A1 BENZOYPARAZINE PYRAZINES ANE THEIR USES FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback